Anesthesia in colonoscopy
Reading File
Finding Sources
Finding Sources
Searching PubMed
colonoscopy sedation anesthesia
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from two major textbooks. Let me compile the full answer.
Anesthesia in Colonoscopy
Overview
Sedation is an integral part of colonoscopy. Its goals are to provide amnesia, analgesia, and anxiolysis without loss of airway patency or ventilatory effort. Most patients tolerate colonoscopy with moderate sedation, though complex procedures, difficult anatomy, or high-acuity patients may require deeper sedation or general anesthesia. Over the past decade, use of monitored anesthesia care (MAC) has increased significantly - more than half of colonoscopies in the US are now performed under MAC.
- Yamada's Textbook of Gastroenterology, 7e
- Miller's Anesthesia, 10e
Continuum of Sedation Depth (ASA Definitions)
| Level | Responsiveness | Airway | Ventilation | CVS |
|---|---|---|---|---|
| Minimal (anxiolysis) | Normal to verbal | Unaffected | Unaffected | Unaffected |
| Moderate (conscious sedation) | Purposeful to verbal/tactile | No intervention needed | Adequate | Usually maintained |
| Deep sedation | Purposeful only to pain | Intervention may be needed | May be inadequate | Usually maintained |
| General anesthesia | Unarousable | Intervention often needed | Frequently inadequate | May be impaired |
The safety margin around moderate sedation is wide, but patients can slip quickly from one level to another - continuous monitoring is mandatory. Note that one study found the mean BIS score in patients receiving nurse-administered propofol was 59, indicating they were functionally under general anesthesia even when labeled as sedation.
Pre-procedure Assessment
- NPO: 6 hours for a light meal, 8 hours for a full meal, 2 hours for clear liquids (in patients without aspiration risk factors such as GERD, gastric dysmotility, DM, bowel obstruction)
- ASA classification and comorbidities guide drug choice and monitoring level
- Patients with OSA, obesity, extreme anxiety, mental disability, movement disorders, or chronic pain may need deeper sedation or GA even for routine procedures
- Anticoagulation status must be reviewed
Pharmacology of Agents Used
Benzodiazepines
| Drug | Onset | Duration | Dose | Notes |
|---|---|---|---|---|
| Midazolam | 2-5 min | 1-3 h | IV: 0.5-2 mg over 2 min; max ~5 mg | Sedation + amnesia; no analgesia; dose reduce 30% if used with opioids; reduce in elderly |
| Diazepam | 3-10 min | 2-8 h | IV: 2.5-5 mg increments | Less amnesic than midazolam; longer duration |
Risk: Respiratory depression (decreased TV and/or RR), potentiated by opioids; paradoxical agitation.
Opioids
| Drug | Onset | Duration | Dose | Notes |
|---|---|---|---|---|
| Fentanyl | 30 s; peak 5-8 min | 0.5-1 h | IV: 50-100 mcg; redose 25-50 mcg q1-2 min | Short-acting; well suited for outpatient colonoscopy |
| Meperidine | 1-3 min; peak 10-15 min | 2-4 h | IV: 25-50 mg; redose 25 mg q5 min | Slower onset; avoid in renal impairment (normeperidine accumulation) |
Opioids provide analgesia with mild sedation. Combined with a benzodiazepine, they form the classic moderate sedation regimen.
Propofol
- Mechanism: Hindered phenolic compound with general anesthetic properties
- Onset: 30-60 seconds
- Duration: 3-10 minutes (rapid recovery)
- Dosing: IV: 20-40 mg slow injection; incremental boluses 10-20 mg every 20 seconds; smaller doses required when combined with opioids or benzodiazepines
- No analgesic effect; weak amnesic effect
- Advantages: Rapid onset, titratable, fast recovery - superior for outpatient colonoscopy throughput
- Disadvantages: Apnea, hypotension, injection-site pain; requires vigilant monitoring
- Administration by non-anesthesiologists (NAPS - nurse-administered propofol sedation) is used in some centers but remains controversial
Safety and efficacy of propofol have been well demonstrated for colonoscopy and EGD. Increasingly, US colonoscopies use propofol, and propofol administration is nearly synonymous with anesthesiologist involvement. - Yamada's Textbook of Gastroenterology, 7e
Remifentanil
- Ultra-short-acting opioid; patients recover earlier than with propofol
- However: more nausea and respiratory depression than propofol groups
- Less commonly used as sole agent
Inhalational Agents (Sevoflurane / Nitrous Oxide)
- When compared with TIVA (propofol + fentanyl + midazolam), inhalational anesthesia patients recovered slower but had less psychomotor impairment at discharge
- TIVA group emerged faster but had longer-lasting psychomotor impairment
Monitoring
Standard intraoperative monitoring is required:
- Pulse oximetry (SpO2) - continuous
- Capnography (ETCO2) - recommended; reduces incidence of O2 desaturation and hypoxemia during propofol sedation for colonoscopy (the ColoCap study)
- Blood pressure (NIBP) - intermittent or continuous
- ECG - especially in cardiac patients
- BIS monitoring - useful to titrate depth, particularly when propofol is used
Stimulating Events During Colonoscopy
The anesthesiologist must anticipate and titrate to moments of increased stimulation:
- Introduction of the endoscope
- Colonic insufflation (with CO2 preferred over air)
- Advancement of scope around flexures
- Biopsy, polypectomy, stenting, dilation, and mucosal resection (endoscopic mucosal resection / ESD) - these require increased analgesia
Reversal Agents
| Agent | Target | Dose | Notes |
|---|---|---|---|
| Flumazenil | Benzodiazepines | 0.2 mg IV; repeat q1 min; max 2 mg | Onset 1-3 min; half-life 53 min (shorter than BZDs - re-sedation may occur); precipitates withdrawal in chronic BZD users; can cause seizures with TCA or carbamazepine |
| Naloxone | Opioids | 0.4-2 mg IV over 30 s; repeat q2-3 min; max 10 mg | Onset 1-2 min; half-life 60-90 min; acute reversal can cause catecholamine surge - tachycardia, hypertension, arrhythmia, pulmonary edema |
Key principle: Try naloxone before flumazenil in combined opioid + benzodiazepine overdose, as most respiratory depression in that setting is opioid-mediated. Elective use of reversal agents to shorten recovery is not recommended.
Role of the Anesthesiologist vs. Non-Anesthesiologist
| Scenario | Typical Approach |
|---|---|
| Healthy patient, routine colonoscopy | Nurse-administered midazolam + opioid (moderate sedation) |
| High-risk/complex patient | Anesthesiologist-directed MAC with propofol |
| Extremely difficult procedure, poor anatomy, uncooperative patient | Deep sedation or GA |
| Pediatric patients | GA preferred |
The use of anesthesiologist-assisted sedation has risen dramatically - from 10.8% in 2010 to 17.3% by 2014, driven by more complex procedures and higher-acuity patients.
Complications
| Complication | Notes |
|---|---|
| Respiratory depression / apnea | Most common serious complication; especially with propofol + opioid combinations |
| Hypotension | Propofol-related; more pronounced with bolus dosing |
| Aspiration | Risk factor for deeper sedation levels |
| Airway obstruction | Risk especially in OSA, obese patients |
| Bowel perforation | Surgical emergency; presents as ongoing abdominal pain post-procedure |
| Bleeding | May occur during therapeutic procedures (polypectomy, ESD); ensure IV access and type & screen |
2025 Evidence Updates
Three recent systematic reviews are relevant:
-
Intravenous lidocaine + propofol for colonoscopy (2025, PMID 40102176): Meta-analysis in Anaesthesia examining whether adding IV lidocaine to propofol-based sedation improves outcomes - currently under evaluation.
-
Ciprofol vs. propofol for GI endoscopy (2025, PMID 40033212 & 40636379): Ciprofol (a novel propofol analogue with less injection pain and more stable hemodynamics) shows comparable safety and efficacy to propofol for colonoscopy and EGD in Chinese patient populations - a potential emerging alternative.
Summary
For routine colonoscopy, midazolam + fentanyl (moderate sedation) remains widely practiced. Propofol-based MAC or TIVA is the standard where anesthesiologist involvement is available, offering superior recovery profiles and procedural conditions, particularly for longer or therapeutic procedures. Monitoring with capnography is strongly recommended. Reversal agents should be reserved for true respiratory emergencies and not used routinely.
Levels of lymph nodes from Bailey’s nd love
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Reading File
Finding Sources
Loading Image
Finding Sources
Reading File
Loading Image
I now have three excellent figures from Bailey and Love's and all the textual content needed. Let me compile the comprehensive answer.
Levels of Lymph Nodes in the Neck
Bailey and Love's Short Practice of Surgery, 28th Edition
The cervical lymph node level system divides the lateral neck into anatomically defined groups based on their relationship to key structures (hyoid bone, SCM, omohyoid, skull base, clavicle). This classification guides neck dissection surgery and oncological staging.
Figure 53.3 - Cervical Lymph Node Levels (Bailey & Love 28th Ed.)
Figure 53.3: Cervical lymph node levels showing IA, IB, IIA, IIB, III, IV, VA, VB and VI.
Figure 55.4 - Detailed Anatomical Relationships
Figure 55.4: Cervical lymph node levels showing relations to hyoid bone, omohyoid muscle, SCM, trapezius, carotid artery, and internal jugular vein.
Figure 52.9 - The Level System (All Seven Levels)
Figure 52.9: The level system for describing location of lymph nodes in the neck showing Levels I-VII. (Reproduced from Stell & Maran's Head and Neck Surgery and Oncology, 5th edn)
The Seven Levels - Detailed Description
| Level | Name | Location / Anatomical Boundaries | Primary Drainage From |
|---|---|---|---|
| I | Submental & Submandibular group | Above hyoid bone; bounded by the anterior and posterior bellies of digastric and the mandible | Floor of mouth, oral tongue, anterior oral cavity, lip |
| IA | Submental | Between the two anterior bellies of digastric, above hyoid | Chin, lower lip, anterior floor of mouth |
| IB | Submandibular | Bounded by anterior and posterior digastric bellies and the mandible; includes submandibular gland | Oral cavity, anterior nasal cavity, soft tissue of mid-face |
| II | Upper Jugular group | From skull base to inferior border of hyoid; posterior to posterior margin of submandibular gland, anterior to posterior border of SCM | Oral cavity, nasal cavity, nasopharynx, oropharynx, hypopharynx, larynx, parotid |
| IIA | Upper jugular (anterior to CN XI) | Anteromedial to the spinal accessory nerve (CN XI) | As above; most commonly involved in H&N SCC |
| IIB | Upper jugular (posterior to CN XI) | Posterolateral to CN XI; often the "jugulodigastric" node area | Nasopharynx, parotid |
| III | Middle Jugular group | From inferior border of hyoid to inferior border of cricoid; between anterior and posterior borders of SCM | Oral cavity, oropharynx, hypopharynx, larynx |
| IV | Lower Jugular group | From inferior border of cricoid to clavicle; between anterior border of SCM and posterior border of SCM | Hypopharynx, larynx, thyroid, cervical esophagus |
| V | Posterior Triangle group | Posterior to posterior border of SCM; from skull base to clavicle | Nasopharynx, oropharynx, scalp, neck skin |
| VA | Spinal accessory nodes | Upper posterior triangle; along CN XI | Nasopharynx, posterior scalp |
| VB | Transverse cervical / supraclavicular | Lower posterior triangle; along transverse cervical vessels | Thyroid, skin of neck/shoulder |
| VI | Anterior Compartment group | Anterior to common carotid arteries bilaterally; from hyoid to manubrium; between the carotid sheaths | Thyroid, larynx (glottis and subglottis), pyriform apex, cervical esophagus |
| VII | Superior Mediastinal nodes | Below manubrium into superior mediastinum (not all classifications include this) | Thyroid, esophagus, trachea |
Metastatic Patterns by Primary Site
As stated in Bailey and Love's:
| Primary Site | Most Common Level(s) Involved |
|---|---|
| Oral cavity (SCC) | I, II, III |
| Lips | I, II, III |
| Oropharynx | II, III |
| Nasopharynx | II, III, V (often bilateral) |
| Larynx (glottis) | II, III, IV |
| Thyroid | VI, then III, IV |
| Cervical esophagus | VI, IV |
Types of Neck Dissection (based on Levels)
| Type | Levels Cleared | Structures Preserved |
|---|---|---|
| Classical Radical Neck Dissection (Crile) | I-V | Nothing - IJV, CN XI, SCM all removed |
| Modified Radical Neck Dissection | I-V (all) | One or more of: CN XI, SCM, IJV preserved |
| Selective Neck Dissection | Selected levels only | SCM, CN XI, IJV preserved; exact levels documented |
"Bulky nodal disease may dictate the need for a radical neck dissection, but this operation is less commonly performed owing to a better understanding of the lymphatic drainage of primary sites."
- Bailey and Love's Short Practice of Surgery, 28th Edition
N-Stage (AJCC 8th Edition TNM) - as in Bailey & Love Table 53.2
| N Category | Criteria |
|---|---|
| NX | Regional nodes cannot be assessed |
| N0 | No regional lymph node metastasis |
| N1 | Single ipsilateral node, ≤3 cm, ENE-negative |
| N2a | Single ipsilateral node >3 cm but ≤6 cm, ENE-negative; OR ≤3 cm ENE-positive |
| N2b | Multiple ipsilateral nodes, none >6 cm, ENE-negative |
| N2c | Bilateral or contralateral nodes, none >6 cm, ENE-negative |
| N3a | Any node >6 cm, ENE-negative |
| N3b | Any node, ENE-positive (except single ipsilateral ≤3 cm ENE+, which is N2a) |
ENE = Extranodal Extension - a key addition in AJCC 8th edition that upstages nodal disease and carries significant prognostic weight.
All content sourced directly from Bailey and Love's Short Practice of Surgery, 28th Edition (ISBN 9780367548117).
This is a shared conversation. Sign in to Orris to start your own chat.